Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Drug Safety Initiative Will Include New Website On Rx Risks

This article was originally published in The Pink Sheet Daily

Executive Summary

The site is intended as an avenue for the agency to disclose safety issues that have not yet been definitively reviewed, and to emphasize the risks with all prescription drugs. The website proposal is understood to be in the internal agency review phase.
Advertisement

Related Content

“Drug Watch” Website Included In FDA’s Rx Safety Reforms
“Drug Watch” Website Included In FDA’s Rx Safety Reforms
U.K. Adverse Events System Will Allow Patients To Submit Reports, Review Data
U.K. Adverse Events System Will Allow Patients To Submit Reports, Review Data
Celebrex, Bextra To Be Targets Of Public Citizen Withdrawal Petition
Celebrex, Bextra To Be Targets Of Public Citizen Withdrawal Petition
FDA Drug Safety Plan Expected Within Two Weeks, Outgoing HHS Secretary Says
FDA Drug Safety Plan Expected Within Two Weeks, Outgoing HHS Secretary Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS061029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel